about
Chronic Rhinosinusitis and the Coagulation SystemMatrix metalloproteinases modulate ameboid-like migration of neutrophils through inflamed interstitial tissuePlasmin inhibitors prevent leukocyte accumulation and remodeling events in the postischemic microvasculature.Control of gene expression by the retinoic acid-related orphan receptor alpha in HepG2 human hepatoma cells.Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator.Biomarkers of systemic inflammation in farmers with musculoskeletal disorders; a plasma proteomic studyExcessive fibrin deposition in nasal polyps caused by fibrinolytic impairment through reduction of tissue plasminogen activator expression.Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps.Mustard Gas Inhalation Injury: Therapeutic Strategy.Immunopathology of chronic rhinosinusitis.Bacterial pathogens activate plasminogen to breach tissue barriers and escape from innate immunity.Immunity and Inflammation in Epilepsy.Murine serum nucleases--contrasting effects of plasmin and heparin on the activities of DNase1 and DNase1-like 3 (DNase1l3).The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style.Focal epilepsy associated with glioneuronal tumors.Blood-brain barrier invasion by Cryptococcus neoformans is enhanced by functional interactions with plasmin.Short chain fatty acids induce tissue plasminogen activator in airway epithelial cells via GPR41&43.An Exploratory Search for Potential Molecular Targets Responsive to the Probiotic PS2 in Women With Mastitis: Gene Expression Profiling vs. Interindividual Variability
P2860
Q26851357-3D1DFA29-C860-4B25-A0FF-9D498D60B010Q30542072-786AE650-9F5D-41E0-A8BB-0724B2B1CCDFQ33833990-23422116-038B-44CB-92A5-F84CECF4F2E0Q33983262-534AE93B-B5C8-4891-B736-0F5D016D790CQ34606581-9BD214A9-EC01-43F6-A710-C671AC1AEEF3Q36012683-A66DD03F-5B97-43DC-8DFE-26405E038329Q36605041-48BF456F-E0CA-4FD1-A059-5D4E92682F6AQ37080005-9AFC666C-21D8-4FE8-8757-CB4CD3A3A5BCQ38209766-52009D90-79E7-4243-A458-0251ACADC6D6Q38403174-6D46D4FC-E85B-40FC-BD76-96A7815BE0FFQ38612236-96EB2312-94F4-4C32-B5ED-844691DBEC18Q38673807-8E0AE39F-6DB7-4671-B17F-7179FB843481Q39893419-4055044C-9621-4579-8928-198E3BE30C75Q40087550-7CCD50E8-C639-4176-907C-05E5C4C6FC25Q40579773-14E6D770-D0CB-4ED5-A447-958B45A304F9Q41968268-115889D3-B5FB-450E-847E-488B6CD3D8F9Q50065287-B7F3078D-4128-4FFE-BD16-ED23C1087D8DQ57110695-5E23334D-8CE0-4E84-8070-40EB79CE6839
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The plasminogen activation system in inflammation.
@en
The plasminogen activation system in inflammation.
@nl
type
label
The plasminogen activation system in inflammation.
@en
The plasminogen activation system in inflammation.
@nl
prefLabel
The plasminogen activation system in inflammation.
@en
The plasminogen activation system in inflammation.
@nl
P2093
P356
P1476
The plasminogen activation system in inflammation
@en
P2093
Francesca Margheri
Marco Pucci
Simona Serrati
P304
P356
10.2741/3032
P577
2008-05-01T00:00:00Z